Clinical trials - Press Releases

Date	Title	Company
03-Jan-2023	Alphalyse and Bavarian Nordic A/S significantly shorten the time necessary to document HCP impurities in COVID-19 vaccine candidate for Phase 3 clinical trial – through world’s first MS-based HCP analysis under GMP conditions	Alphalyse
03-Jan-2023	HUTCHMED Completes Patient Enrollment of ESLIM-01, a Phase III Trial of Sovleplenib in Primary Immune Thrombocytopenia in China	HUTCHMED
22-Dec-2022	Hataali and Reef Group announce strategic partnership for ATMP Smart Labs	Hataali
22-Dec-2022	OSE Immunotherapeutics Announces First Patient Dosed with Anti-PD1 Monoclonal Antibody OSE-279 in a Phase 1/2 Clinical Trial in Advanced Solid Tumors or Lymphomas	OSE Immunotherapeutics
22-Dec-2022	Kancera submits regulatory application to conduct clinical study in ovarian cancer and enters into collaboration with the Nordic Society of Gynaecological Oncology	Kancera
21-Dec-2022	Innovative Antibody Discovered by RQ Bio Enters Clinic as Part of Antibody Combination Within 12 Months of Discovery	RQ Bio
20-Dec-2022	Clinical trial platform provider encapsia welcomes new COO	encapsia
20-Dec-2022	Novotech is Gold Sponsor at Biotech Showcase 2023	Novotech Health Holdings Pte Ltd
16-Dec-2022	Calypso Biotech Announces First Patient with Eosinophilic Esophagitis Dosed in Anti-Interleukin-15 (IL-15) Monoclonal Antibody CALY-002 Phase 1a/b Trial, and Animal Proof of Concept Data in Atopic Dermatitis	Calypso Biotech
16-Dec-2022	Tiziana Life Sciences Announces Completion of Prerequisite Pre-Clinical Safety Study	Tiziana Life Sciences
15-Dec-2022	CellProthera expands clinical trial sites for phase IIb myocardial infarction study	CellProthera
15-Dec-2022	CellProthera expands clinical trial sites for phase IIb myocardial infarction study	CellProthera
15-Dec-2022	THOUSANDS OF PATIENTS WITH TERMINAL LUNG SCARRING GIVEN ACCESS TO DRUGS THAT COULD PROLONG THEIR LIVES	• Action for Pulmonary Fibrosis
15-Dec-2022	Data Shows 50% of New Trials Have Sites in Asia Pacific	Novotech Health Holdings Pte Ltd
15-Dec-2022	ImaginAb Launches Phase II C-IT Neo Trial using CD8+ Cell Imaging to Investigate Neoadjuvant Immunotherapy	ImaginAb
15-Dec-2022	Preventing Strokes and Heart Attacks Doesn't Have to Come with the Risk of Life-threatening Bleeding	Verseon International Corporation
14-Dec-2022	Conference Co-chairs from Merck & AstraZeneca invitation to join 3D Cell Culture	SAE Media Group
13-Dec-2022	Enterome completes patient enrollment of Phase 2 ROSALIE study evaluating its lead immunotherapy, EO2401, in recurrent glioblastoma	Enterome
13-Dec-2022	Curebase Releases Diagnostic Offering that Delivers First All-Inclusive Package of Software and Services Needed to Fully Execute Diagnostic Studies	Curebase
13-Dec-2022	CluePoints Appoints Andy Cooper as New Chief Executive Officer	CluePoints